microRNA-323 upregulation promotes prostate cancer growth and docetaxel resistance by repressing p73

Global cancer statistics, 2012

Lindsey A. Torre, Freddie Bray, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians · 2015 · 27.4K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer

Daniel P. Petrylak, Catherine M. Tangen, Maha Hussain et al. · New England Journal of Medicine · 2004 · 3.7K citations · Full text

Pharmacy, Oncology, Pharmacotherapy +13

Distinctive Patterns of MicroRNA Expression Associated with Karyotype in Acute Myeloid Leukaemia

Amanda Dixon‐McIver, Charles A. Mein, Jean‐Baptiste Cazier et al. · PLoS ONE · 2008 · 272 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

miR‐34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression

Claire Corcoran, Sweta Rani, Lorraine O’Driscoll · The Prostate · 2014 · 219 citations · Full text

Medicine, Molecular Biology, Oncology +17

miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1

Yuan Wang, Rachel Lieberman, Jing Pan et al. · Molecular Cancer · 2016 · 188 citations · Full text

Medicine, Oncology, Pharmacology +17